Figure 2From: FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: A meta-analysis of 2618 cases and 2305 controls Forest plot of prostate cancer progression associated with FGFR4 Gly 388 Arg polymorphism (Arg/Arg vs . Gly/Gly+Gly/Arg). The squares and horizontal lines correspond to the study-specific OR and 95% CI. The area of the squares reflects the weight (inverse of the variance). The diamond represents the summary OR and 95% CI.Back to article page